Your session is about to expire
← Back to Search
Micronutrient for Autism
Study Summary
This trial will investigate whether micronutrients can improve ASD symptoms in children, as well as changes in metabolites.
- Autism
- Autism Spectrum Disorder
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does ingesting Micronutrient pose any health risks to individuals?
"There is some evidence that Micronutrient produces a safe result, so it has been assigned an indicative score of 2. Unfortunately, no data currently exists to demonstrate efficacy."
Is participation in this research open to those under 55 years of age?
"The qualifications for this trial specify that prospective participants are between 5 and 22 years old. Altogether, there are 212 trials available to minors and 41 studies available to seniors."
What criteria must be met for one to be eligible for enrollment in this trial?
"This clinical trial is targeting 20 individuals, aged 5 to 22 years old, who have been clinically diagnosed with Autism Spectrum Disorder. Selected participants must be male or female and enrolled at OHS; additionally, consent from the legal guardian of each participant needs to be obtained in writing as well as confirmation that they are able to comply with all study requirements. The diagnosis will need to adhere to DSM-IV criteria and medical records must be reviewed by an experienced clinician for corroboration."
Is enrollment for this trial available at the present time?
"Clinicaltrials.gov indicates that the registration period for this trial has been closed since October 4th 2022, however there are presently 252 other trials actively seeking new patients."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger